Yoga Windhu Wardhana

Dr. Yoga Windhu Wardhana

Department Pharmaceutics and Pharmaceutical Technology, Universitas Padjadjaran, Bandung, Jawa Barat, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
AHAulia Fikri Hidayat
Aulia Fikri Hidayat
Yoga Windhu WardhanaYoga Windhu Wardhana
Yoga Windhu Wardhana
SSSuwendar Suwendar
Suwendar Suwendar
AMAhmed Fouad Abdelwahab Mohammed
Ahmed Fouad Abdelwahab Mohammed
SMSafwat Mahmoud
Safwat Mahmoud
Nasrul WathoniNasrul Wathoni
Nasrul Wathoni
Oral administration is the most preferred route for drug delivery due to its convenience, non-invasiveness, and patient compliance. However, it is challenged by gastrointestinal barriers, enzymatic degradation, and first-pass metabolism, which reduce drug bioavailability. Lipid nanoparticles (LNPs), including solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), offer a promising strategy to overcome these limitations by enhancing drug stability, permeability, and absorption. The Quality by Design (QbD) framework provides a systematic approach for LNP development to ensure consistent product quality. By promoting process understanding and control, QbD not only supports scientific formulation development but also enhances industrial scalability by reducing the experimental workload, shortening the development time, and lowering the production costs. This review highlights key QbD elements such as the quality target product profile (QTPP), critical quality attributes (CQAs), critical material attributes (CMAs), critical process parameters (CPPs), and design of experiments (DoE) and their roles in guiding formulation and process optimization. The effects of various CMAs and CPPs on the CQAs such as particle size, polydispersity index, encapsulation efficiency, zeta potential, and drug release are discussed. Furthermore, the in vitro, in vivo, and ex vivo performances of optimized LNPs were explored in detail. Overall, QbD offers a robust platform for the rational design and scalable production of high-quality lipid-based drug delivery systems for oral administration.

21 August 2022 in Polymers
Verified
Journal Article
Open access
PDF file
SSSuryani Suryani
Suryani Suryani
ACAnis Yohana Chaerunisaa
Anis Yohana Chaerunisaa
IJI Made Joni
I Made Joni
RRRuslin Ruslin
Ruslin Ruslin
LRLa Ode Ahmad Nur Ramadhan
La Ode Ahmad Nur Ramadhan
SSSitti Hadijah Sabarwati
Sitti Hadijah Sabarwati
Low molecular weight chitosan (LMWC) has higher solubility and lower viscosity allowing for a wider pharmaceutical application compared to high molecular weight chitosan. LMWC chitosan can be obtained through a chitosan depolymerization process. This research aimed to produce LWMC using the combination of formic acid and ultrasonication method with the optimal condition of the depolymerization process. The chitosan depolymerization method was performed by combining formic acid and ultrasonication. The optimum conditions of the depolymerization process were obtained using the Box–Behnken design. The LMWC obtained from depolymerization was characterized to identify its yield, degree of deacetylation, the molecular weight, structure, morphology, thermal behavior, and crystallinity index. Results: The characterization results of LWMC obtained from the depolymerization process using the optimum conditions showed that the yield was 89.398%; the degree of deacetylation was 98.076%; the molecular weight was 32.814 kDa; there was no change in the chemical structure, LWMC had disorganized shape, there was no change in the thermal behavior, and LWMC had a more amorphous shape compared to native chitosan. Conclusion: The production of LWMC involving depolymerization in the presence of weak acid and ultrasonication can be developed by using the optimal condition of the depolymerization process.

23 June 2022 in Polymers
Verified
Journal Article
Open access
PDF file
NANuur Aanisah
Nuur Aanisah
Yoga Windhu WardhanaYoga Windhu Wardhana
Yoga Windhu Wardhana
ACAnis Yohana Chaerunisaa
Anis Yohana Chaerunisaa
ABArif Budiman
Arif Budiman
Glucomannan (GM)—a polysaccharide generally extracted from the tuber of Amorphophallus konjac—has great potential as a filler–binder in direct compression, disintegrant in tablets, or gelling agent due to its strong hydrophilicity and extremely high viscosity. However, it has poor water resistance and low mechanical strength when used as an excipient in solid form. Several physical and chemical modifications have been carried out to improve these drawbacks. Chemical modification affects the characteristics of GM based on the DS. Carboxymethylation improves GM functionality by modifying its solubility and viscosity, which in turn allows it to bind water more efficiently and thus improve its elongation and gel homogeneity. Meanwhile, physical modification enhances functionality through combination with other excipients to improve mechanical properties and modify swelling ability and drug release from the matrix. This review discusses extraction of GM and its modification to enhance its applicability as an excipient in solid form. Modified GM is a novel excipient applicable in the pharmaceutical industry for direct compression, as a tablet disintegrant, a film-forming agent, and for encapsulation of macromolecular compounds or drug carriers for controlled release.

21 November 2022 in Gels
Verified
Journal Article
Open access
PDF file
Yoga Windhu WardhanaYoga Windhu Wardhana
Yoga Windhu Wardhana
NANuur Aanisah
Nuur Aanisah
ISiyan sopyan
iyan sopyan
RHRini Hendriani
Rini Hendriani
ACAnis Yohana Chaerunisaa
Anis Yohana Chaerunisaa
The physicochemical properties of κ-carrageenan gels and their ester forms derived from different fatty-acid saturations were characterized and compared with those of native κ-carrageenan. Furthermore, stearic and oleic acids were used as the saturated and unsaturated fatty acids, respectively. Fourier-transform infrared (FTIR) spectra confirmed the introduction of the ester into the κ-carrageenan backbone. The thermogravimetric analysis showed that thermal stability increased along with the level of unsaturation, but there was a decrease in viscosity, hardness, and syneresis, which caused the consistency of the product to become more elastic. The results also showed that the ester form still has a swelling ability that is almost the same as that of κ-carrageenan. After being formulated into a gel dosage form, the product was successfully produced from the ester with unsaturated fatty acids, and it was more elastic than native κ-carrageenan and had good physical properties with spreadability that meets the requirements for topical preparations.

14 January 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YHYedi Herdiana
Yedi Herdiana
Yoga Windhu WardhanaYoga Windhu Wardhana
Yoga Windhu Wardhana
IKInsan Sunan Kurniawansyah
Insan Sunan Kurniawansyah
DGDolih Gozali
Dolih Gozali
Nasrul WathoniNasrul Wathoni
Nasrul Wathoni
FSFerry Ferdiansyah Sofian
Ferry Ferdiansyah Sofian
The deposition of monosodium urate (MSU) crystals within joint spaces produces a painful inflammatory condition known as gout, a specific form of arthritis. The condition calls for a combined curative and preventive management model. A new development in the approach to gout is that of NLRP3-targeted biologic agents, such as monoclonal therapies, to provide more accurate treatment by blocking specific pro-inflammatory cytokines. Nanoparticle drug delivery enhances biological availability and delivery to targets, which may increase therapeutic efficacy and decrease general toxicity. The preventive approach again cannot be ignored, mainly keeping up certain modifications in diet and weight, along with pharmacological therapies to reduce uric acid (UA) levels and to decrease the frequency of acute attacks. The advancement of genetic profiling of patients and biomarker discoveries drives the trend towards building individualized medicine and care, quickly gaining ground as the most effective method of delivering treatments to individual patients, moving away from one-size-fits-all treatments. The following paper aims to provide an updated account of the management of gout with a focus on recent developments, in order to enhance these approaches, the quality of life for patients with gout, and the standard of gout treatment.

1 August 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
ABArif Budiman
Arif Budiman
ARAgus Rusdin
Agus Rusdin
Yoga Windhu WardhanaYoga Windhu Wardhana
Yoga Windhu Wardhana
LPLisa Efriani Puluhulawa
Lisa Efriani Puluhulawa
FMFaradila Ratu Cindana Mo’o
Faradila Ratu Cindana Mo’o
Diah Lia AulifaDiah Lia Aulifa
Diah Lia Aulifa
Antioxidants are essential for reducing oxidative stress, protecting cells from damage, and supporting overall well-being. Functionalized mesoporous silica materials have garnered interest due to their flexible uses in diverse domains, such as drug delivery systems. This review aims to thoroughly examine and evaluate the progress made in utilizing functionalized mesoporous silica materials as a possible approach to enhancing antioxidant activity. The authors performed a thorough search of reliable databases, including Scopus, PubMed, Google Scholar, and Clarivate Web of Science, using precise keywords linked to functionalized mesoporous silica nanoparticles and antioxidants. The identified journals serve as the major framework for the main discussion in this study. Functionalized mesoporous silica nanoparticles have been reported to greatly enhance antioxidant activity by allowing for an increased loading capacity, controlled release behavior, the targeting of specific drugs, improved biocompatibility and safety, and enhanced penetration. The results emphasize the significant capacity of functionalized mesoporous silica (FSM) to bring about profound changes in a wide range of applications. FSM materials can be designed as versatile nanocarriers, integrating intrinsic antioxidant capabilities and augmenting the efficacy of current drugs, offering substantial progress in antioxidant therapies and drug delivery systems, as well as enhanced substance properties in the pharmaceutical field. Functionalized mesoporous silica materials are a highly effective method for enhancing antioxidant activity. They provide new opportunities for the advancement of cutting-edge treatments and materials in the field of antioxidant research. The significant potential of FSM materials to change drug delivery methods and improve substance properties highlights their crucial role in future breakthroughs in the pharmaceutical field and antioxidant applications.